<main class="html-publication" lang="en" role="main">
      

  <div class="publication-external">
    <ul class="organisation-logos">
        <li class="organisation-logos__logo">
          
<div class="gem-c-organisation-logo brand--department-of-health">
    <a class="gem-c-organisation-logo__container gem-c-organisation-logo__link brand__border-color" href="/government/organisations/nhs-commissioning-board">
      <span class="gem-c-organisation-logo__name">NHS England</span>
</a>
</div>
        </li>
    </ul>
  </div>

  <header class="gem-c-inverse-header  gem-c-inverse-header--padding-top ">
    
  

<div class="gem-c-title gem-c-title--inverse govuk-!-margin-top-8 govuk-!-margin-bottom-0">
      <span class="govuk-caption-xl gem-c-title__context">
    Guidance
  </span>


  <h1 class="gem-c-title__text govuk-heading-xl">
    Data
  </h1>
</div>
  <p class="publication-header__last-changed">Updated 5 July 2022</p>

  </header>




  <section class="gem-c-devolved-nations">
    <h2 class="govuk-heading-s govuk-!-margin-bottom-0">
      Applies to England
</h2>
</section>

<div class="govuk-grid-row sidebar-with-body" data-module="sticky-element-container">

  <div class="print-wrapper">
    <div class="print-meta-data">
      <p>
  <img class="print-meta-data-licence" src="/assets/government-frontend/open-government-licence-min-93b6a51b518ff99714a1aa2a7d2162735c155ec3cb073c75fb88b2a332fa83d3.png">
</p>
<p>
  © Crown copyright 2022
</p>
<p>
  This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit <a href="https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3">nationalarchives.gov.uk/doc/open-government-licence/version/3</a> or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: <a href="mailto:psi@nationalarchives.gov.uk">psi@nationalarchives.gov.uk</a>.
</p>
<p>
  Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
</p>
<p>
  This publication is available at https://www.gov.uk/government/publications/fetal-anomaly-screening-programme-handbook/data
</p>


    </div>
  </div>

  <div class="main-content-container offset-empty-contents-list">
    <div class="gem-c-govspeak-html-publication">
  
<div class="gem-c-govspeak govuk-govspeak " data-module="govspeak">
    
    
      <div class="govspeak">
<p>For naming conventions used throughout this guidance and other general information, please read the <a class="govuk-link" href="/government/publications/fetal-anomaly-screening-programme-handbook/overview">Overview</a> page.</p>

<hr>

<p><a class="govuk-link" href="https://www.gov.uk/government/organisations/public-health-england/about">Public Health England (<abbr title="Public Health England">PHE</abbr>)</a> publishes reports setting out <a class="govuk-link" href="https://www.gov.uk/government/publications/fetal-anomaly-screening-programme-standards-data-report">annual data</a> collected from the NHS <abbr title="fetal anomaly screening programme">FASP</abbr>.</p>

<p><abbr title="Public Health England">PHE</abbr> publishes a <a class="govuk-link" href="https://www.gov.uk/government/publications/antenatal-screening-standards-data-report-2017-to-2018">joint antenatal screening standards data report</a>.</p>

<h2>
<span class="number">1. </span>Screening standards</h2>

<p><a class="govuk-link" href="https://www.gov.uk/government/publications/fetal-anomaly-screening-programme-standards">Screening standards</a> provide a way of measuring how well screening programmes are performing in important areas.</p>

<p><a class="govuk-link" href="https://www.gov.uk/government/publications/nhs-population-screening-reporting-data-definitions/antenatal-and-newborn-screening-kpis-for-2018-to-2019-definitions">Key performance indicators</a> (<abbr title="key performance indicators">KPIs</abbr>) are a subset of the screening standards for the NHS screening programmes.</p>

<h2>
<span class="number">2. </span>Data submissions</h2>

<p>The NHS <abbr title="fetal anomaly screening programme">FASP</abbr> will monitor the detection rates (<abbr title="detection rate">DR</abbr>) and screen positive rates (<abbr title="screen positive rate">SPR</abbr>) of the <a class="govuk-link" href="/government/publications/fetal-anomaly-screening-programme-handbook/screening-for-downs-syndrome-edwards-syndrome-and-pataus-syndrome--3#combined-test">combined</a> and <a class="govuk-link" href="/government/publications/fetal-anomaly-screening-programme-handbook/screening-for-downs-syndrome-edwards-syndrome-and-pataus-syndrome--3#quadruple-test">quadruple</a> tests against performance thresholds set for the national programme.</p>

<p>In Down’s syndrome, Edwards’ syndrome and Patau’s syndrome screening the <abbr title="detection rate">DR</abbr> and <abbr title="screen positive rate">SPR</abbr> increase with maternal age.</p>

<h3>
<span class="number">2.1 </span>Down’s syndrome quality assurance support service (<abbr title="Down's syndrome screening quality support service">DQASS</abbr>)</h3>

<p><a class="govuk-link" href="https://www.gov.uk/government/publications/fetal-anomaly-screening-programme-standards/fetal-anomaly-screening-standards-valid-from-1-april-2020#fasp-s03a-test-screen-positive-rate-t21t18t13-screening">Test performance standard <abbr title="fetal anomaly screening programme">FASP</abbr>-S03a</a> is reported by <a class="govuk-link" href="https://www.gov.uk/guidance/downs-syndrome-screening-quality-assurance-support-service"><abbr title="Down's syndrome screening quality support service">DQASS</abbr></a>.</p>

<p>The table below outlines <abbr title="screen positive rate">SPR</abbr> which are standardised according to the maternal age distribution of England. This data relates to both singleton and twin pregnancies.</p>

<table>
  <thead>
    <tr>
      <th scope="col">Screening strategy</th>
      <th scope="col">Expected standardised SPR (%)</th>
      <th scope="col">Acceptable standardised SPR (%)</th>
      <th scope="col">Achievable standardised SPR (%)</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Combined (<abbr title="trisomy 21 (Down's syndrome)">T21</abbr>, <abbr title="trisomy 18 (Edward's syndrome)">T18</abbr> and <abbr title="trisomy 13 (Patau's syndrome)">T13</abbr>)</td>
      <td>2.6</td>
      <td>2.2 to 3.0</td>
      <td>2.3 to 2.9</td>
    </tr>
    <tr>
      <td>Combined (joint <abbr title="trisomy 18 (Edward's syndrome)">T18</abbr> and <abbr title="trisomy 13 (Patau's syndrome)">T13</abbr>)</td>
      <td>&lt;0.2</td>
      <td>0.1 to 0.2</td>
      <td>0.13 to 0.17</td>
    </tr>
    <tr>
      <td>Combined (<abbr title="trisomy 21 (Down's syndrome)">T21</abbr>)</td>
      <td>2.6</td>
      <td>2.2 to 3.0</td>
      <td>2.3 to 2.9</td>
    </tr>
    <tr>
      <td>Quadruple (<abbr title="trisomy 21 (Down's syndrome)">T21</abbr> only)</td>
      <td>3.6</td>
      <td>3.2 to 4.0</td>
      <td>3.3 to 3.9</td>
    </tr>
  </tbody>
</table>

<p>The table below outlines <abbr title="detection rate">DR</abbr> for the conditions screened for in both singleton and twin pregnancies.</p>

<p><abbr title="detection rate">DR</abbr> are standardised according to the maternal age distribution in England.</p>

<table>
  <thead>
    <tr>
      <th scope="col">Condition (screening test)</th>
      <th scope="col">Standardised DR for singleton (%)</th>
      <th scope="col">Standardised DR for monochorionic twins (%)</th>
      <th scope="col">Standardised DR for dichorionic twins (%)</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>
<abbr title="trisomy 21 (Down's syndrome)">T21</abbr> (combined)</td>
      <td>86</td>
      <td>86</td>
      <td>&gt;80</td>
    </tr>
    <tr>
      <td>
<abbr title="trisomy 18 (Edward's syndrome)">T18</abbr>, <abbr title="trisomy 13 (Patau's syndrome)">T13</abbr> (combined)</td>
      <td>80</td>
      <td>80</td>
      <td>80</td>
    </tr>
    <tr>
      <td>
<abbr title="trisomy 21 (Down's syndrome)">T21</abbr> (quadruple)</td>
      <td>82</td>
      <td>82</td>
      <td>50</td>
    </tr>
  </tbody>
</table>

<h3>
<span class="number">2.2 </span>National Congenital Anomaly and Rare Disease Registration Service (<abbr title="National Congenital and Rare Diseases Registration Service">NCARDRS</abbr>)</h3>

<p><a class="govuk-link" href="https://www.gov.uk/government/publications/fetal-anomaly-screening-programme-standards/fetal-anomaly-screening-standards-valid-from-1-april-2020#fasp-s03b-test-detection-rate-t21t18t13-screening">Test performance standard <abbr title="fetal anomaly screening programme">FASP</abbr>-S03b</a> is reported by <a class="govuk-link" href="https://www.gov.uk/guidance/the-national-congenital-anomaly-and-rare-disease-registration-service-ncardrs"><abbr title="National Congenital and Rare Diseases Registration Service">NCARDRS</abbr></a>.</p>

<p>Screening laboratories must provide a monthly report of all higher chance results from the combined test and quadruple test. This report must use the data set requirements provided by the <abbr title="National Congenital and Rare Diseases Registration Service">NCARDRS</abbr> team for antenatal screening.</p>

<p>Providers also have a role in reporting to <abbr title="National Congenital and Rare Diseases Registration Service">NCARDRS</abbr> using the <a class="govuk-link" href="https://www.gov.uk/government/publications/ncardrs-antenatal-data-collection">antenatal</a>, <a class="govuk-link" href="https://www.gov.uk/government/publications/ncardrs-delivery-data-collection">delivery</a> and <a class="govuk-link" href="https://www.gov.uk/government/publications/ncardrs-postnatal-data-collection">postnatal</a> data collection forms.</p>

<p>Thresholds for performance for the 11 physical conditions screened for at the <a class="govuk-link" href="/government/publications/fetal-anomaly-screening-programme-handbook/20-week-screening-scan">20-week screening scan</a> are shown in the table below.</p>

<table>
  <thead>
    <tr>
      <th scope="col">Physical conditions</th>
      <th scope="col">Detection rate thresholds (%)</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Anencephaly</td>
      <td>98</td>
    </tr>
    <tr>
      <td>Spina bifida</td>
      <td>90</td>
    </tr>
    <tr>
      <td>Cleft lip</td>
      <td>75</td>
    </tr>
    <tr>
      <td>Congenital diaphragmatic hernia</td>
      <td>60</td>
    </tr>
    <tr>
      <td>Gastroschisis</td>
      <td>98</td>
    </tr>
    <tr>
      <td>Exomphalos</td>
      <td>80</td>
    </tr>
    <tr>
      <td>Serious cardiac conditions including transposition of the great arteries, atrioventricular septal defect,  tetralogy of fallot and hypoplastic left heart syndrome</td>
      <td>50</td>
    </tr>
    <tr>
      <td>Bilateral renal agenesis</td>
      <td>84</td>
    </tr>
    <tr>
      <td>Lethal skeletal dysplasia</td>
      <td>60</td>
    </tr>
    <tr>
      <td>Edwards’ syndrome</td>
      <td>95</td>
    </tr>
    <tr>
      <td>Patau’s syndrome</td>
      <td>95</td>
    </tr>
  </tbody>
</table>

</div>


</div>
</div>
  </div>

  <div class="sticky-element" data-sticky-element="">
    <a class="govuk-link app-c-back-to-top dont-print" href="#contents">
    <svg class="app-c-back-to-top__icon" focusable="false" height="17" viewBox="0 0 13 17" width="13" xmlns="http://www.w3.org/2000/svg">
      <path d="M6.5 0L0 6.5 1.4 8l4-4v12.7h2V4l4.3 4L13 6.4z" fill="currentColor"></path>
    </svg>
    Contents
</a>

    <div class="sticky-element__print-link">
      
<div class="gem-c-print-link govuk-!-display-none-print govuk-!-margin-top-0 govuk-!-margin-bottom-6">
    <button class="govuk-link govuk-body-s gem-c-print-link__button" data-module="print-link">Print this page</button>
</div>
    </div>
  </div>
</div>

    </main>